United Therapeutics (UTHR)
$358.9 2%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
9 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on United Therapeutics, AI stock picks, stock alerts and much more.
UTHR AI Stock Analysis
AI stock analysis for UTHR is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like United Therapeutics (UTHR) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
UTHR Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of United Therapeutics (UTHR), currently trading at $358.9, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About UTHR
-
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
-
Symbol
UTHR
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
16B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$22.78 0.5% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.08 8.9% |
4 |
 |
Moderna MRNA |
$34.06 0.9% |
4 |
 |
Anavex Life Sciences AVXL |
$9.21 9.3% |
6 |
 |
BridgeBio Pharma BBIO |
$33.79 0.9% |
7 |
News
UTHR Alternative Data
News Mentions
Sign up to access
Twitter Followers
Sign up to access
Facebook Engagement
Sign up to access
Instagram Followers
Sign up to access
LinkedIn Followers
Sign up to access
Job Postings
Sign up to access
LinkedIn Employees
Sign up to access
Web Traffic
Sign up to access
Business Outlook
Sign up to access
UTHR Financials
UTHR Key Metrics
-
Total Revenue
$748.9M
-
Net Income
$309.1M
-
Earnings per Share
$6.93
-
Free cash flow
$300.7M
-
EBITDA
$417.8M
-
EBITDA Ratio
0.557885
-
Total Assets
$7.1B
UTHR 2-year Revenue & Income
UTHR 2-year Free Cash Flow
UTHR Technicals
UTHR SMA
UTHR RSI
FAQ
What's the current price of United Therapeutics (UTHR) Stock?
The price of an United Therapeutics (UTHR) share is $358.9.
What's the market cap of United Therapeutics?
The current market cap of United Therapeutics is 16B.
Should I buy or sell UTHR?
Multiple alternative data signals suggest that United Therapeutics stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is United Therapeutics a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in United Therapeutics stock. The bullish indicators suggest that United Therapeutics' growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy United Therapeutics (UTHR) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying United Therapeutics stock, given the bullish outlook.
What are some stocks similar to United Therapeutics (UTHR) that investors often compare it to?
United Therapeutics (UTHR) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for United Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast United Therapeutics' stock price to be around $383.1 in 2026. Starting from the current price of $358.9, this represents a 6.7% change in price, indicating a bullish outlook for the stock.
How to buy United Therapeutics (UTHR) Stock?
United Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy United Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.